Depression Research Update: March 2016

March 1, 2016
Mark L. Fuerst

The guidelines and research discussed in this slideshow assess the benefits of various therapies for depressive disorders.

The guidelines and research discussed in this slideshow assess the benefits of various therapies for depressive disorders.1-3 Scroll through the slides for recommendations, findings, and take-home messages.

References:

1. Qaseem A, Barry MJ, Kansagara D; Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Feb 9. doi:10.7326/M15-2570.
2. US Food and Drug Administration. Electroconvulsive therapy (ECT) devices for class II intended uses draft guidance for industry, clinicians and Food and Drug Administration staff. http://www.regulations.gov/#!documentDetail;D=FDA-2014-D-1318-0002. Published December 29, 2015. Accessed February 23, 2016.
3. Mehlum L, Ramberg M, Tørmoen AJ, et al. Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. J Am Acad Child Adolesc Psychiatry. 2016 Jan 27. doi: http://dx.doi.org/10.1016/j.jaac.2016.01.005.